Search Results

OSI-930 10 mg  | 99.76%

TargetMol

OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.

More Information Supplier Page

OSI-930 50 mg  | 99.76%

TargetMol

OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.

More Information Supplier Page

OSI-930 5 mg  | 99.76%

TargetMol

OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.

More Information Supplier Page

KN-93 10 mg  | 99.78%

TargetMol

KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase.

More Information Supplier Page